An observational study in Migraine, sponsored by Swiat Zdrowia. Completed at 2 sites in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-04.
Sponsored by Swiat Zdrowia · Observational
A survey of Polish respondents will aim to define migraine characteristics in Polish subjects. To achieve this, a structured questionnaire based mainly on American Migraine Prevalence and Prevention Study has been prepared to serve as a tool for data extraction. The obtained data should allow for defining disease parameters, burden and received treatments. Additionally questions regarding patients rhinological symptoms and COVID-19-related history were included.
1,528 studies on the registry are indexed under Migraine Disorders; 299 are open to participants now.
This study's enrollment of 2,800 is above the median of 130 across 299 observational studies indexed under Migraine Disorders.
Browse Migraine Disorders studies →Swiat Zdrowia is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Participant will be recruited from miscellaneous sources including: specialist headache practices, primary care clinics, patients associations. An invitation would be also extended via social and traditional media and employers.
Exclusion Criteria:
Headache phenotype
Classification of reported headache according to International Classification of Headache Disorders
Time frame: in the preceding year
Migraine burden
Consequences of the disease measured by the Migraine Disability Assessment Test
Time frame: in the preceding year
Monthly headache days
Number of days per month
Time frame: in the preceding month
Monthly headache days
Number of days per year
Time frame: in the preceding year
Time from last headache professional consultation
Number of months
Time frame: in the preceding 10 years
Migraine diagnosed by headache professional
yes/no
Time frame: in the preceding 10 years
Age at diagnosis
years
Time frame: from the onset of headache (time frame up to 99 years)
Comoribidities
Disease according to International Classsification of Disease 10
Time frame: in the preceding year
Type of previous headache professional consultation
Name of headache profession/speciality
Time frame: in the preceding 10 years
Number of consultations in the last year
Number 0-100
Time frame: in the last 12 months
Number of consultations in the last year because of headaches
Number 0-100
Time frame: in the last 12 months
Number of days spent in hospital in the last year because of headaches
Number 0-100
Time frame: in the last 12 months
Acute treatment used
Name of abortive medication
Time frame: in the preceding 10 years
Preventive treatment used
Name of abortive medication
Time frame: in the preceding 10 years
Acute treatment frequency
Number of days per month
Time frame: in the last 3 months
Preventive treatment frequency
Number of months form the last dose
Time frame: in the last 12 months
Preventive treatment effectiveness
Likert scale
Time frame: in the last 12 months
Employment
Type of employment
Time frame: in the last 12 months
Time spent at work
Number of hours per week
Time frame: in the last 12 months
Work absence due to headache
Number of days per month
Time frame: in the last month
Presenteeism
Number of days per month
Time frame: in the last month
PHQ-9 Patient Health Questionnaire
Number
Time frame: in the last 2 weeks
Sinus headache
Number of days
Time frame: in the last 3 months
Sinonasal symptoms accompanying headache
Type of symptoms
Time frame: in the last 12 months
Sinonasal symptoms not associated with headache
Type of symptom
Time frame: in the last 12 months
COVID-19 association with headache
Likert scale
Time frame: in the last 2 years
COVID-19 vaccine association with headache
Likert scale
Time frame: in the last year
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Swiat Zdrowia